Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1

Conditions

Myelodysplastic Syndromes 185Leukemia, Myeloid, Acute 165Precursor Cell Lymphoblastic Leukemia-Lymphoma 127Leukemia 116Leukemia, Lymphocytic, Chronic, B-Cell 95Hodgkin Disease 94Multiple Myeloma 92Lymphoma, Non-Hodgkin 89Myeloproliferative Disorders 86Lymphoma 77Leukemia, Myelogenous, Chronic, BCR-ABL Positive 75Lymphoma, Mantle-Cell 69Lymphoma, Follicular 69Congenital Abnormalities 68Leukemia, Myelomonocytic, Chronic 66Leukemia, Myeloid, Chronic-Phase 66Leukemia, Myeloid, Accelerated Phase 64Lymphoma, Large B-Cell, Diffuse 62Burkitt Lymphoma 62Lymphoma, B-Cell, Marginal Zone 61Primary Myelofibrosis 55Blast Crisis 52Lymphoma, Large-Cell, Immunoblastic 51Anemia, Refractory, with Excess of Blasts 47Neoplasms, Plasma Cell 46Myelodysplastic-Myeloproliferative Diseases 39Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 38Dendritic Cell Sarcoma, Interdigitating 37Waldenstrom Macroglobulinemia 34Recurrence 34

Interventions

Imatinib Mesylate 12nilotinib 3bosutinib 3peginterferon alfa-2a 2asciminib 2Dasatinib 2Azacitidine 24-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 2venetoclax 1thymoglobulin 1flumatinib 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Vincristine 1Tyrosine Kinase Inhibitors 1Tacrolimus 1Rituximab 1Mycophenolic Acid 1Melphalan 1Interferons 1Dexamethasone 1Clofarabine 1Busulfan 1Bone Marrow Transplantation 1Blood Specimen Collection 1Antilymphocyte Serum 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Philadelphia Chromosome × fludarabine phosphate × Myeloid × Clear all
NCT01471067 2017-04-28

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
33 enrolled
LymphoidMyeloidOther hematologic neoplasm

Pathologic Complete Response, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Philadelphia Chromosome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡